Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $52 at Baird
Tweet
Share
E-mailGet Alerts AMLX Hot Sheet
Price: $31.90 -0.59%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Baird analyst Joel Beatty raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $52.00 (from $28.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Jersey Mike's Subs (JMKE) PT Raised to $30 at Tigress Financial Partners
- Sembcorp Industries (SCI:SP) PT Lowered to SGD6.39 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
